PRECIGEN Investors


Combined Otolaryngology Spring Meetings (COSM)

May 15 - May 19, 2024

Precigen to participate in the 2024 COSM annual meeting taking place in Chicago from May 15 to May 19, 2024. On May 16 at 4:21 PM CT, Dr. Clint T. Allen, MD, Principal Investigator with the Section on Translational Tumor Immunology at the National Institutes of Health and a lead investigator for the PRGN-2012 clinical study, will present "Clinical Benefit following Adjuvant Therapeutic Vaccination with PRGN-2012 in Adult Patients with RRP."


Chicago, Illinois